findmyKOL
Clinical trialNCT05268939CompletedObservational

Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment

SponsorLumiraDx UK LimitedEnrollment589COVID-19Influenza AInfluenza Type BRSV Infection
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx SARS-CoV-2 \& FLU A/B Test, and LumiraDx SARS-CoV-2 \& RSV Test at Point of Care Testing Sites. Subjects presenting with symptoms suggestive of COVID-19 and/or Influenza and/or RSV will be consented and asked to donate swab sample(s) for testing in the device(s) under evaluation.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cullman Clinical Trials

    Cullman, Alabama, United States

  • Diagnamics, Inc

    Encinitas, California, United States

  • Marisela Gonzalez, Md, Pa

    Miami, Florida, United States

  • Excellence Medical and Research

    Miami Gardens, Florida, United States

  • Koch Family Medicine

    Morton, Illinois, United States

  • Benchmark Research

    Covington, Louisiana, United States

  • Machuca Foundation

    Las Vegas, Nevada, United States

  • Clinical Research Solutions

    Middleburg Heights, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Jan 2022
Primary completion
25 Apr 2022
Completion
14 Mar 2023
Last update posted
15 Jun 2026
Registered enrollment
589
Registry id
NCT05268939
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.